Pinetree Therapeutics Patents – Insights & Stats (Updated 2023)

Pinetree Therapeutics has a total of 26 patents globally, out of which 8 have been granted. Of these 26 patents, more than 69% patents are active. The USA is where Pinetree Therapeutics has filed the maximum number of patents, followed by Europe, Australia and Canada. Parallelly, Korea (South) seems to be the main focused R&D centre and also USA is the origin country of Pinetree Therapeutics.

Pinetree Therapeutics was founded in 2019. Pinetree Therapeutics pioneers ground-breaking treatments for cancer, focusing on both traditional oncology and immuno-oncology, aiming to revolutionize cancer care through innovative therapies.

Do read about some of the most popular patents of Pinetree Therapeutics which have been covered by us in this article and also you can find Pinetree Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pinetree Therapeutics patent portfolio.

How many patents does Pinetree Therapeutics have?

Pinetree Therapeutics has a total of 26 patents globally. These patents belong to 6 unique patent families. Out of 26 patents, 18 patents are active.

How Many Patents did Pinetree Therapeutics File Every Year?

Pinetree Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPinetree Therapeutics Applications FiledPinetree Therapeutics Patents Granted
202321
202221
202164
20201
201911
201841
20171
20168
20141

How many Pinetree Therapeutics patents are Alive/Dead?

Worldwide Patents

Pinetree Therapeutics Patent Portfolio

How Many Patents did Pinetree Therapeutics File in Different Countries?

Pinetree Therapeutics Worldwide Patent Filing

Countries in which Pinetree Therapeutics Filed Patents

CountryPatent
United States Of America10
Europe (EPO)4
Australia2
Canada2
Mexico1
Denmark1
Spain1
Austria1
Italy1
Germany1

Where are Research Centers of Pinetree Therapeutics Patents Located?

R&D Centres of Pinetree Therapeutics

What Percentage of Pinetree Therapeutics US Patent Applications Were Granted?

Pinetree Therapeutics (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 42.86%.

Below are the key stats of Pinetree Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Pinetree Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Jonathan P O’Brien PhD633.33%
United One Law Group Llc10%

List of Pinetree Therapeutics patents

Pinetree Therapeutics PatentsTitle
US11548915B2Composition For Overcoming Resistance To Egfr-Targeting Agent
US10400022B2Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
US9975933B2Tumor Tissue-Penetrating Peptide Specific To Neuropilin And Fusion Protein Having Same Peptide Fused Therein
US20230312684A1Neuropilin And Angiotensin Converting Enzyme 2 Fusion Peptides For Treating Viral Infections
US20230257422A1Composition For Overcoming Resistance To Egfr-Targeting Agent
EP3275895B1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
EP4188415A2Neuropilin And Angiotensin Converting Enzyme 2 Fusion Peptides For Treating Viral Infections
EP3978519A1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
EP3680250A4Composition For Restraining Activity Of Regulatory T Cell, Comprising Peptide Binding Specifically To Neuropilin 1 (Nrp1)
ES2894299T3Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused Thereto And Use Thereof
DK3275895T3Neuropilin-1-Specific Binding Peptide, Fusion Protein Fused Thereto, And Use Thereof
DE602016062757T2Neuropilin-1-Specific Binding Peptide, Fusion Protein Fused With It And Use Thereof
IT202100086807T2Peptide Binding Specifically Neuropilin-1, Fusion Protein Fused With The Same And Their Use
WO2023192514A1Bispecific Antibodies Comprising An Nrp1 Binding Domain And Methods Of Use Thereof
AU2021315818A1Neuropilin And Angiotensin Converting Enzyme 2 Fusion Peptides For Treating Viral Infections
CA3187747A1Neuropilin And Angiotensin Converting Enzyme 2 Fusion Peptides For Treating Viral Infections
CA3075403A1Composition For Restraining Activity Of Regulatory T Cell, Comprising Peptide Binding Specifically To Neuropilin 1 (Nrp1)
MX2023001366ANeuropilin And Angiotensin-Converting Enzyme 2 Fusion Peptides For The Treatment Of Viral Infections
US20220298220A1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
US20210198340A1Neuropilin-1 Specific Binding Peptides And Its Fusion Protein, And Use Thereof
US20200362010A1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
US20200276328A1Composition For Restraining Activity Of Regulatory T Cell, Comprising Peptide Binding Specifically To Neuropilin 1 (Nrp1)
US20200010526A1Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused With Same, And Use Thereof
WO2022026943A3Neuropilin And Angiotensin Converting Enzyme 2 Fusion Peptides For Treating Viral Infections
AT1423721TNeuropilin-1-Spezifisches Bindungspeptid, Damit Fusioniertes Fusionsprotein Und Verwendung Davon
AU2018327940A1Composition For Restraining Activity Of Regulatory T Cell, Comprising Peptide Binding Specifically To Neuropilin 1 (Nrp1)

What are Pinetree Therapeutics key innovation segments?

What Technologies are Covered by Pinetree Therapeutics?

The chart below distributes patents filed by Pinetree Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Pinetree Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Pinetree Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pinetree Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.